Acino International AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Acino International AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5165
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acino International AG (Acino), formerly Acino Holding AG, manufactures and commercializes generic and prescription pharmaceuticals in novel drug delivery forms. The company focuses on the therapeutic areas of oncology, cardiology and metabolism, central nervous system, gastroenterology, infectiology, pain and rheumatology, respiratory, urology and women’s health, among others. It also offers business-to-business services such as product development, registration and contract manufacturing. The company’s drug delivery technologies focus on modified release oral forms and oral dispersible forms. Acino has manufacturing facilities in Estonia, Switzerland and Ukraine. The company markets products in the Middle East, Latin America, Africa, Europe and Asia. Acino is headquartered in Zurich, Switzerland.

Acino International AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino International AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Private Equity 17
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Partnerships 18
Acino International Enters into Distribution Agreement with Merck 18
Licensing Agreements 19
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 19
Asset Transactions 20
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 20
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 21
Acquisition 22
Acino Pharma Acquires Litha Healthcare from Endo International 22
Acino Pharma Acquires Pharma Start 23
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 24
Acino International AG – Key Competitors 26
Acino International AG – Key Employees 27
Acino International AG – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Corporate Communications 30
Jun 04, 2018: Steffen Saltofte appointed CEO Acino Group 30
Feb 15, 2017: Appointment of Mario Ricard as COO and member of the Executive Committee 31
Jan 23, 2017: Resignation of Barthold Piening, Chief Operations Officer 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Acino International AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9
Acino International AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Acino Pharma Acquires Three Products from Tabuk Pharma 11
Acino International Acquires Manufacturing Business from Takeda Pharma 12
Norgine Divests its MENA Operations and Product Rights to Acino 13
Aspen Pharmacare to Divest Business Unit to Litha Pharma for USD134 Million 14
Acino Pharma Completes Acquisition Of Asia, Latin America, Middle East And Africa Businesses From Mepha For US$123 Million 15
Avista Capital And Nordic Capital To Acquire Acino For US$439.93 Million 17
Acino International Enters into Distribution Agreement with Merck 18
Iroko Pharma Enters into Licensing Agreement with Litha Pharma for ZORVOLEX 19
Westrate Trade and Invest and Immunotek to Acquire Device, Vaccine and Non-Core Business Lines from Litha Healthcare 20
Life Sciences Management Group Acquires Iclaprim Business from Acino Pharma 21
Acino Pharma Acquires Litha Healthcare from Endo International 22
Acino Pharma Acquires Pharma Start 23
Litha Healthcare Group Completes Acquisition Of Pharmaplan From Paladin Labs For US$60.7 Million 24
Acino International AG, Key Competitors 26
Acino International AG, Key Employees 27
Acino International AG, Subsidiaries 28

List of Figures
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acino International AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acino International AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Acino International AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acino International AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acino International AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Acino International AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wilmar International Limited:企業の戦略・SWOT・財務情報
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sturm, Ruger & Company, Inc.:企業の戦略・SWOT・財務情報
    Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sturm, Ruger & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Majestic Wine plc (WINE):企業の財務・戦略的SWOT分析
    Majestic Wine plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sino Gas & Energy Holdings Ltd (SEH):企業の財務・戦略的SWOT分析
    Summary Sino Gas & Energy Holdings Ltd (Sino Gas), a subsidiary of MIE Holdings Corp, is an oil and gas company that explores and develops unconventional gas assets production sharing contracts. The company holds working interest in the Linxing PSC and the Sanjiaobei PSC projects. It has strategic A …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • TTK Prestige Limited:企業の戦略・SWOT・財務分析
    TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report Summary TTK Prestige Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Greenphire Inc:医療機器:M&Aディール及び事業提携情報
    Summary Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions that offers patients reimbursement and site payments. The company’s products portfolio includes ClinCard, ConneXTS and eClinicalGPS. Its eClinicalGPS is a global site that facilitates accurate payment calculation, …
  • China Bohai Bank Co., Ltd:企業の戦略・SWOT・財務情報
    China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Pack Corporation
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Guangzhou R&F Properties Co Ltd:戦略・SWOT・企業財務分析
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Natura Cosmeticos SA:戦略・SWOT・企業財務分析
    Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report Summary Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • American Overseas Group Limited:企業の戦略・SWOT・財務分析
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Bank Gutmann AG:企業の戦略・SWOT・財務情報
    Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report Summary Bank Gutmann AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆